How AI-Powered Cell Culture Could Revolutionize Drug Discovery
In this opinion piece, Vice President of Strategy and Innovation Shantanu Dhamija discusses how widespread adoption of organoids has been hindered by the labor-intensive and error-prone nature of their development and maintenance.
Following the launch of our CellXpress.ai™ Automated Cell Culture System, he explores how the advent of artificial intelligence (AI) is transforming this landscape, offering end-to-end automation of cell culture experiments, generating both 2D and 3D cellular models, and overseeing the entire organoid journey by automating tasks like feeding and passaging. This breakthrough eliminates the time-consuming and mundane aspects of organoid studies, paving the way for scalable and reproducible research in drug discovery.